Clinical Research Directory

Inclusion Criteria: * Must have a body mass index (BMI) between 19.0 and 32.0 kilograms per meter squared (kg/m²) at study screening * Must be Human Immunodeficiency Virus (HIV) negative by HIV 1/0/2 testing. * Must be Hepatitis B (HBV) surface antigen negative * Must be Hepatitis C (HCV) antibody negative * Females must have a negative serum pregnancy test Exclusion Criteria: * Pregnant or lactating subjects * Have previously participated in an investigational trial involving administration of any investigational compound within 30 days prior to the study dosing * Current alcohol or substance abuse judged by the Investigator to potentially interfere with subject compliance * Have smoked or used tobacco/nicotine products within 90 days prior to the study dosing * Have been treated with systemic steroids, immunosuppressant therapies or chemotherapeutic agents within 3 months of study screening, or expected to receive these agents during the study (e.g., corticosteroids, immunoglobulins, and other immune- or cytokine-based therapies) * Have been vaccinated within 90 days of study dosing